Basilea joins INCATE to support antifungal innovation

January 13, 2026 — INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting the advancement of early stage anti-infectives, announced today a partnership with Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections. Basilea is joining…